Kincell Bio Capacity Update April 2025: Cell & Gene Therapy

Kincell Bio partners to advance cell therapies for innovators and patients. With manufacturing facilities located in Research Triangle Park, North Carolina, and Gainesville, Florida, Kincell Bio is a contract development and manufacturing organization (CDMO) with the mission to streamline CMC development, apply expertise in analytical and process development, and GMP supply from early clinical to pivotal studies and product launch. Kincell Bio is focused on supporting innovative companies developing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs, as well as developing expertise in stem cell products and iPSCs.

This talk will showcase Kincell’s ability to apply extensive scientific knowledge in CMC development to set the foundation for later-stage clinical supply and commercialization. Below, we describe our experience in providing clinical CAR-T products to the clinic for more than five years and our plans to deliver a pivotal drug product for patients. We will also describe our path to expand our operational capabilities for commercial readiness to meet the needs of our clients who are rapidly advancing to commercialization.